Opportunity Information: Apply for PA 07 113
Apply for PA 07 113
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Dec 7, 2006.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education County governments State governments For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) City or township governments Small businesses Independent school districts Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R01)" (Funding Opportunity Number PA-07-113) is a National Institutes of Health (NIH) grant announcement focused on improving the quality and effectiveness of drug abuse treatment in real-world community settings. It is issued in connection with the National Institute on Drug Abuse (NIDA) Clinical Trials Network, a large, established research partnership that links drug abuse researchers with more than 150 community treatment programs (CTPs) across multiple sites in the United States. The central idea is to use this nationwide practice-based infrastructure to study how treatment programs can improve what they do, why certain improvement efforts succeed or fail, and how to develop stronger methods for evaluating and sustaining those improvements.
The purpose of the announcement is to solicit health services research that takes advantage of the CTN environment to address practice improvement in community treatment programs. In practical terms, this means projects are expected to look beyond whether a clinical intervention works in a controlled setting and instead examine how treatment practices are adopted, implemented, adapted, and maintained in routine care. The FOA highlights two main research directions: first, investigating system-level factors that help or hinder practice improvement within community treatment programs (for example, organizational leadership, workforce capacity, financing and reimbursement structures, regulations, referral networks, information systems, and local service ecosystems); and second, developing or refining research tools and methods that make health services research on practice improvement more rigorous, feasible, and informative when conducted in busy, real-world treatment settings. The CTN is positioned as the enabling platform because it serves diverse populations of people who use drugs and includes many different types of treatment providers, giving researchers access to varied settings where implementation challenges and solutions can be studied at scale.
This opportunity uses the NIH R01 mechanism, which is generally intended for more substantial, hypothesis-driven research projects that require a larger scope, longer duration, and more comprehensive approach than smaller exploratory awards. The announcement notes that it runs in parallel with two other FOAs with the same scientific scope but different grant mechanisms: an R21 version (PA-06-496) aimed at exploratory/developmental research and an R03 version (PA-06-497) aimed at small research projects. Applicants who have a well-developed research plan that needs the scale and resources of an R01 would target PA-07-113, while those with more preliminary or narrowly scoped ideas might consider the companion FOAs.
Funding is described in conditional terms: awards depend on the availability of funds and on receiving a sufficient number of highly meritorious applications. The announcement does not promise a specific number of awards or a fixed budget amount within the text provided, which is common for NIH program announcements where final funding decisions depend on annual appropriations, program priorities, and peer review outcomes. The program is categorized as discretionary and uses the standard grant funding instrument type. It is associated with CFDA number 93.279 (Drug Abuse and Addiction Research Programs). There is no cost sharing or matching requirement, meaning applicants are not required to commit non-federal matching funds as a condition of the award.
Eligibility is broad and intentionally inclusive to encourage participation from many sectors involved in health services research and treatment delivery. Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status, state and local governments (including counties, cities, townships, special district governments, and independent school districts), public housing authorities/Indian housing authorities, Native American tribal governments (federally recognized) and other tribal organizations, for-profit organizations (including small businesses and other for-profits), and other entities as described in the full announcement. The FOA explicitly notes that foreign institutions are eligible to apply, that eligible federal government agencies may apply, and that faith-based or community-based organizations may also apply. This wide eligibility reflects the reality that meaningful practice improvement research often requires collaboration among academic researchers, treatment providers, policymakers, and community organizations.
In terms of timing and submission, the opportunity was originally posted on December 7, 2006, with multiple receipt dates rather than a single deadline, which indicates an ongoing or cyclical submission structure typical of many NIH opportunities. Both the original and current closing date fields specify "Multiple Receipt Dates" and direct applicants to the full announcement for details. The archive date is October 2, 2009, signaling that while the FOA was active during that period, it has since been archived; anyone looking to apply now would need to find a current, active successor announcement or related NIDA/NIH funding opportunity with similar goals.
Overall, PA-07-113 is best understood as an NIH/NIDA effort to strengthen the evidence base for how drug abuse treatment programs improve routine care, using the CTN as a national laboratory for implementation and health services research. The emphasis is on practical, systems-aware studies that can explain and accelerate real-world improvements in community treatment settings, while also advancing the methods and tools needed to measure and support those improvements reliably across diverse programs and populations. For full technical requirements, receipt dates, and application instructions, the FOA points to the detailed announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-07-113.html and provides NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R01)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PA-07-113.
Which federal agency and institute are associated with this opportunity?
This is a National Institutes of Health (NIH) grant announcement associated with the National Institute on Drug Abuse (NIDA).
What is the main goal of PA-07-113?
The main goal is to support health services research that improves the quality and effectiveness of drug abuse treatment in real-world community settings, using the National Drug Abuse Clinical Trials Network (CTN) as the research environment.
What is the Clinical Trials Network (CTN) and why is it central to this FOA?
The CTN is a large practice-based research partnership that links drug abuse researchers with more than 150 community treatment programs (CTPs) across multiple sites in the United States. It is central to this FOA because it provides nationwide, real-world infrastructure where practice improvement can be studied across diverse programs, providers, and patient populations.
What types of organizations are considered "community treatment programs" (CTPs) in this context?
In the context provided, CTPs are the community-based drug abuse treatment programs connected to the CTN network (more than 150 programs across multiple U.S. sites). The FOA positions these programs as routine-care settings where implementation challenges and improvement efforts can be observed and evaluated.
What kind of research does the FOA encourage?
The FOA encourages health services research focused on practice improvement in community treatment programs. This includes examining how treatment practices are adopted, implemented, adapted, and maintained in routine care (not just whether an intervention works in a controlled research setting).
What are the main research directions highlighted in the FOA?
The FOA highlights two main directions: (1) studying system-level factors that help or hinder practice improvement within community treatment programs, and (2) developing or refining research tools and methods to make practice-improvement health services research more rigorous and feasible in busy, real-world settings.
What are examples of system-level factors the FOA is interested in?
Examples listed include organizational leadership, workforce capacity, financing and reimbursement structures, regulations, referral networks, information systems, and local service ecosystems.
Is this FOA about testing whether a clinical intervention works?
The emphasis is on moving beyond controlled-setting efficacy questions and focusing on real-world practice improvement: how practices are implemented, adopted, adapted, sustained, and why improvement efforts succeed or fail in routine community treatment settings.
What grant mechanism does this opportunity use?
This opportunity uses the NIH R01 mechanism.
What does using the R01 mechanism imply about project scope?
The R01 mechanism is generally intended for substantial, hypothesis-driven research that may require larger scope, longer duration, and a more comprehensive approach than smaller exploratory or pilot projects.
Are there related funding opportunities with similar scientific scope?
Yes. The announcement notes two companion FOAs with the same scientific scope but different mechanisms: an R21 version (PA-06-496) for exploratory/developmental research and an R03 version (PA-06-497) for small research projects.
How should an applicant choose between the R01, R21, and R03 versions mentioned?
Based on the information provided: applicants with a well-developed plan that needs the scale and resources of an R01 would target PA-07-113, while applicants with more preliminary or narrowly scoped ideas might consider the companion R21 (PA-06-496) or R03 (PA-06-497) announcements.
Is there a guaranteed funding amount or number of awards stated?
No. The information provided states that awards depend on the availability of funds and the receipt of a sufficient number of highly meritorious applications. It does not specify a fixed budget amount or number of awards.
What factors affect whether awards are made?
Awards are described as conditional on the availability of funds and on receiving enough highly meritorious applications (consistent with typical NIH program announcements where funding depends on appropriations, priorities, and peer review outcomes).
What is the CFDA number associated with this program?
The associated CFDA number is 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The information provided states there is no cost sharing or matching requirement.
What type of funding instrument is used?
It uses the standard grant funding instrument type, and the program is categorized as discretionary.
Who is eligible to apply?
Eligibility is broad. Eligible applicants include public and private institutions of higher education; nonprofits with or without 501(c)(3) status; state and local governments (including counties, cities, townships, special district governments, and independent school districts); public housing authorities/Indian housing authorities; Native American tribal governments (federally recognized) and other tribal organizations; for-profit organizations (including small businesses); and other entities as described in the full announcement.
Are foreign institutions eligible to apply?
Yes. The FOA explicitly notes that foreign institutions are eligible to apply.
Can federal government agencies apply?
Yes. The FOA indicates that eligible federal government agencies may apply.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly notes that faith-based or community-based organizations may apply.
When was this FOA originally posted?
The opportunity was originally posted on December 7, 2006.
Does this FOA have a single application deadline?
No. The information provided indicates "Multiple Receipt Dates" rather than a single deadline, and it directs applicants to the full announcement for specific receipt-date details.
Is this funding opportunity still active?
The information provided states the archive date is October 2, 2009, and notes that the FOA has been archived. Anyone looking to apply now would need to identify a current, active successor or related NIH/NIDA funding opportunity with similar goals.
Where can applicants find the full announcement and official instructions?
The FOA points to the detailed announcement page at http://grants.nih.gov/grants/guide/pa-files/PA-07-113.html for full technical requirements, receipt dates, and application instructions.
Who should be contacted for access or linking issues related to the announcement page?
The information provided indicates NIH Office of Extramural Research (OER) webmaster contacts are provided for access or linking issues.
What is the overall intent of PA-07-113 in plain terms?
In plain terms, PA-07-113 aims to strengthen the evidence base for how drug abuse treatment programs improve routine care, using the CTN as a national platform to study implementation challenges and solutions across varied community treatment settings, while also advancing the research methods needed to measure and sustain improvements.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R01)
Previous opportunity: Behavioral and Integrative Treatment Development Program (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 113
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 113) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pathophysiology of Bisphosphonates associated Osteonecrosis of the Jaw (R01) Apply for PA 07 132 Funding Number: PA 07 132 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Development Of Frontal Cortex And Limbic System And Their Roles In Drug Abuse Or Mental Health (R01) Apply for PA 07 121 Funding Number: PA 07 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Sarcoidosis Research into the Cause of Multi organ Disease and Clinical Strategies for Therapy (R01) Apply for PA 07 136 Funding Number: PA 07 136 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Building Translational Research in Integrative Behavioral Science (R01) Apply for PAR 07 155 Funding Number: PAR 07 155 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics And Genomics Of Drug Addiction (R03) Apply for PA 07 168 Funding Number: PA 07 168 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Functional Genetics and Genomics of Drug Addiction (R21) Apply for PA 07 167 Funding Number: PA 07 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Functional Genetics And Genomics Of Drug Addiction (R01) Apply for PA 07 166 Funding Number: PA 07 166 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pathogenesis And Treatment Of Lymphedema And Lymphatic Diseases (R01) Apply for PA 07 165 Funding Number: PA 07 165 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Studies of Energy Balance and Cancer in Humans (R01) Apply for PA 07 176 Funding Number: PA 07 176 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Memory T Lymphocytes in Cancer Immunology (R01) Apply for PA 07 255 Funding Number: PA 07 255 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims Based Data (R01) Apply for PA 07 254 Funding Number: PA 07 254 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Information Technologies and the Internet in Health Services and Intervention Delivery (R01) Apply for PA 07 295 Funding Number: PA 07 295 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epigenetic Approaches in Cancer Epidemiology (R21) Apply for PA 07 299 Funding Number: PA 07 299 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epigenetic Approaches in Cancer Epidemiology (R01) Apply for PA 07 298 Funding Number: PA 07 298 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R21) Apply for PA 07 309 Funding Number: PA 07 309 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R03) Apply for PA 07 308 Funding Number: PA 07 308 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse Aspects of HIV/AIDS (R01) Apply for PA 07 307 Funding Number: PA 07 307 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Clinical Decision Making in Life Threatening Illness (R21) Apply for PA 07 316 Funding Number: PA 07 316 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) NIDA (R03) Apply for PAS 07 327 Funding Number: PAS 07 327 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Drug Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PAS 07 326 Funding Number: PAS 07 326 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 113", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
